Literature DB >> 8784123

Angiotensin-converting enzyme gene polymorphism in hypertensive individuals with parental history of stroke.

Y Maeda1, U Ikeda, H Ebata, Y Hojo, Y Seino, Y Hayashi, S Kuroki, K Shimada.   

Abstract

BACKGROUND AND
PURPOSE: It has been suggested that the insertion (I)/deletion (D) polymorphism of the angiotensin-converting enzyme (ACE) gene is an independent risk factor for coronary artery disease, but its relation to stroke has not yet been proven. We investigated an association of ACE gene polymorphism with parental history of stroke (PHS) in patients with hypertension.
METHODS: We studied 70 hypertensive patients (ambulatory blood pressure > 140/90 mm Hg; age, 59 +/- 11 years) with (n = 27) or without (n = 43) PHS, defined as either one or both parents having had a stroke before 60 years of age. The ACE genotype was analyzed by polymerase chain reaction.
RESULTS: Casual blood pressure and mean ambulatory blood pressure levels were not significantly different between patients with and without PHS. The incidence of left ventricular hypertrophy also did not differ significantly between the two groups. However, the frequency of the D allele was significantly higher in patients with PHS (0.72) than in patients without PHS (0.52) (chi 2 = 5.472, P = .019). The frequency of the DD genotype of the ACE gene was also significantly higher in patients with than in those without PHS (DD, 63.0%; ID, 18.5%; II, 18.5% versus DD, 32.6%; ID, 39.5%; II, 27.9%; chi 2 = 6.395, P = .041).
CONCLUSIONS: The DD genotype of the ACE gene is associated with PHS in patients with hypertension, which is independent of blood pressure levels or presence of cardiac hypertrophy.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8784123     DOI: 10.1161/01.str.27.9.1521

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  6 in total

1.  Meta-analysis of the ACE gene in ischaemic stroke.

Authors:  P Sharma
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-02       Impact factor: 10.154

2.  Coronary artery disease and endothelial nitric oxide synthase and angiotensin-converting enzyme gene polymorphisms.

Authors:  H Nakagami; U Ikeda; Y Maeda; K Yamamoto; Y Hojo; K Kario; S Kuroki; K Shimada
Journal:  J Thromb Thrombolysis       Date:  1999-10       Impact factor: 2.300

Review 3.  Genetics of arterial hypertension and hypotension.

Authors:  Dieter Rosskopf; Markus Schürks; Christian Rimmbach; Rafael Schäfers
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-01-30       Impact factor: 3.000

4.  ACE and AT1R gene polymorphisms and hypertension in Indian population.

Authors:  T F Ashavaid; K K Shalia; K G Nair; J J Dalal
Journal:  J Clin Lab Anal       Date:  2000       Impact factor: 2.352

5.  Angiotensin-Converting Enzyme Gene Polymorphism and Plasminogen Activator Inhibitor 1 Levels in Subjects with Cerebral Infarction.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1998-07       Impact factor: 2.300

6.  The association between gene polymorphisms and leukocytosis with thrombotic complications in patients with essential thrombocythemia and polycythemia vera.

Authors:  Ozgür Mehtap; Elif Birtaş Ateşoğlu; Pınar Tarkun; Emel Gönüllü; Hakan Keski; Yıldıray Topçu; Nilüfer Uzülmez; Deniz Sünnetçi; Abdullah Hacıhanefioğlu
Journal:  Turk J Haematol       Date:  2012-06-15       Impact factor: 1.831

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.